Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ligusticum + chuanxiong refers to a combination of herbal ingredients derived from the rhizome of Ligusticum chuanxiong, also known as Chuanxiong or Szechwan lovage root. In traditional Chinese medicine (TCM), Ligusticum chuanxiong is one of the 50 fundamental herbs and is widely used for its ability to activate blood circulation, dissolve blood stasis, dispel wind, relieve pain, and support cardiovascular and cerebrovascular health[1][2][4][6]. The main bioactive compounds include phthalides (such as ligustilide) and alkaloids, which contribute to its anti-inflammatory, antioxidant, antithrombotic, vasodilatory, antispasmodic, analgesic (pain-relieving), immune-enhancing, anti-bacterial and anti-fungal effects[1][3][4][5]. It is commonly used in formulas for treating hematological disorders such as ischemia and thrombosis; it also supports menstrual health by nourishing blood and relieving pain associated with menstruation[1][4]. Modern research highlights its pharmacological activities in protecting against cerebral ischemia/reperfusion injury and myocardial ischemia while improving microcirculation[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ligusticum + chuanxiong.